These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1585402)

  • 1. Audit exposes flawed blood sampling for "digoxin levels".
    Kumana CR; Chan YM; Kou M
    Ther Drug Monit; 1992 Apr; 14(2):155-8. PubMed ID: 1585402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of requests for serum digoxin concentrations: experience from an Australian regional health service.
    Ellington C; Grgurinovich N; Miners JO; Mangoni AA
    Br J Clin Pharmacol; 2007 May; 63(5):623-7. PubMed ID: 17073890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An audit of requests for therapeutic drug monitoring of digoxin: problems and pitfalls.
    Clague HW; Twum-Barima Y; Carruthers SG
    Ther Drug Monit; 1983; 5(3):249-54. PubMed ID: 6636251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin therapeutic drug monitoring: an audit and review.
    Sidwell A; Barclay M; Begg E; Moore G
    N Z Med J; 2003 Dec; 116(1187):U708. PubMed ID: 14752536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma digoxin concentration fluctuations associated with timing of plasma sampling and amiodarone administration.
    DeVore KJ; Hobbs RA
    Pharmacotherapy; 2007 Mar; 27(3):472-5. PubMed ID: 17316159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Making digoxin therapeutic drug monitoring more effective.
    Matzuk MM; Shlomchik M; Shaw LM
    Ther Drug Monit; 1991 May; 13(3):215-9. PubMed ID: 1926274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A concurrent audit of high digoxin plasma levels.
    Piergies AA; Worwag EM; Atkinson AJ
    Clin Pharmacol Ther; 1994 Mar; 55(3):353-8. PubMed ID: 8143400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use and misuse of a digoxin assay service.
    Gibb I; Cowan JC; Parnham AJ; Thomas TH
    Br Med J (Clin Res Ed); 1986 Sep; 293(6548):678-80. PubMed ID: 3756451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriateness of digoxin level monitoring.
    Mordasini MR; Krähenbühl S; Schlienger RG
    Swiss Med Wkly; 2002 Sep; 132(35-36):506-12. PubMed ID: 12506332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of data collection method on results of serum digoxin concentration audit.
    Makela EH; Davis SK; Piveral K; Miller WA; Pleasants RA; Gadsden RH; Leman RB
    Am J Hosp Pharm; 1988 Jan; 45(1):126-30. PubMed ID: 3348225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin therapeutic drug monitoring practices. A College of American Pathologists Q-Probes study of 666 institutions and 18,679 toxic levels.
    Howanitz PJ; Steindel SJ
    Arch Pathol Lab Med; 1993 Jul; 117(7):684-90. PubMed ID: 8323428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nighttime dosing assures postdistribution sampling for therapeutic drug monitoring of digoxin.
    Bernard DW; Bowman RL; Grimm FA; Wolf BA; Simson MB; Shaw LM
    Clin Chem; 1996 Jan; 42(1):45-9. PubMed ID: 8565231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the appropriateness of digoxin level monitoring.
    Cañas F; Tanasijevic MJ; Ma'luf N; Bates DW
    Arch Intern Med; 1999 Feb; 159(4):363-8. PubMed ID: 10030309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of digoxin: help or hindrance?
    Dobbs RJ; Nicholson PW; Denham MJ; Dobbs SM; O'Neill CJ
    Eur J Clin Pharmacol; 1986; 31(4):491-5. PubMed ID: 3816929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate digoxin monitoring.
    Copeland RJ; Thorpe H; Kay EA
    J Clin Pharm Ther; 1992 Jun; 17(3):173-4. PubMed ID: 1639878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a model based on body composition to predict drug kinetics; II. Application of the model to the use of digoxin in elderlies.
    Ferrara S; Pazzucconi F; Bondioli A; Mombelli G; Agrati A; Ferraro G; Zoppi F; De Rosa C; Calabresi L; Sirtori CR
    Pharmacol Res; 2004 Jul; 50(1):105-8. PubMed ID: 15082036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Educational intervention to improve appropriate digoxin therapeutic drug monitoring: a quasi-experimental study.
    Oncu S; Baskurt A; Senturk B; Aslan O; Kume T; Ucku R; Gelal A
    Eur J Hosp Pharm; 2021 Nov; 28(6):320-324. PubMed ID: 34697048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between high serum digoxin levels and toxicity.
    Tuncok Y; Hazan E; Oto O; Guven H; Catalyurek H; Kalkan S
    Int J Clin Pharmacol Ther; 1997 Sep; 35(9):366-8. PubMed ID: 9314088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring.
    Englund G; Hallberg P; Artursson P; Michaëlsson K; Melhus H
    BMC Med; 2004 Apr; 2():8. PubMed ID: 15061868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin toxicity: an evaluation in current clinical practice.
    Williamson KM; Thrasher KA; Fulton KB; LaPointe NM; Dunham GD; Cooper AA; Barrett PS; Patterson JH
    Arch Intern Med; 1998 Dec 7-21; 158(22):2444-9. PubMed ID: 9855382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.